These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

157 related items for PubMed ID: 6348345

  • 1. [Clinical trials of hypoxic cell sensitizer misonidazole].
    Onoyama Y.
    Gan No Rinsho; 1983 May; 29(6):718-25. PubMed ID: 6348345
    [Abstract] [Full Text] [Related]

  • 2. Clinical trials of misonidazole in the United States.
    Wasserman TH, Stetz J, Phillips TL.
    Cancer Clin Trials; 1981 May; 4(1):7-16. PubMed ID: 7214664
    [Abstract] [Full Text] [Related]

  • 3. Misonidazole in the clinic at Mount Vernon.
    Dische S.
    Cancer Clin Trials; 1980 May; 3(2):175-8. PubMed ID: 7000388
    [Abstract] [Full Text] [Related]

  • 4. [Clinical evaluation of hypoxic cell sensitizer (Misonidazole)].
    Asakawa H, Watarai J, Hoshino T.
    Gan To Kagaku Ryoho; 1984 Jun; 11(6):1225-30. PubMed ID: 6732250
    [Abstract] [Full Text] [Related]

  • 5. [Present status of radiation sensitizers--hypoxic cell radiosensitizer].
    Murayama C, Mori T.
    Gan To Kagaku Ryoho; 1989 Jun; 16(6):2135-41. PubMed ID: 2660744
    [Abstract] [Full Text] [Related]

  • 6. [Radiation sensitizers: with special reference to hypoxic cell sensitizers].
    Onoyama Y, Nakajima T, Tanaka M.
    Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 1):894-903. PubMed ID: 3963856
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Phase I trial of intravenous L-phenylalanine mustard plus the sensitizer misonidazole.
    Coleman CN, Friedman MK, Jacobs C, Halsey J, Ignoffo R, Leibel S, Hirst VK, Gribble M, Carter SK, Phillips TL.
    Cancer Res; 1983 Oct; 43(10):5022-5. PubMed ID: 6883348
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. New side effect of the hypoxic cell sensitizer, misonidazole.
    Partington J, Koziol D, Chapman D, Rabin H, Urtasun RC.
    Cancer Treat Rep; 1979 Jan; 63(1):123-5. PubMed ID: 217536
    [Abstract] [Full Text] [Related]

  • 12. Clinical evaluation of nitroimidazoles as modifiers of hypoxia in solid tumors.
    Overgaard J.
    Oncol Res; 1994 Jan; 6(10-11):509-18. PubMed ID: 7620219
    [Abstract] [Full Text] [Related]

  • 13. [Present status of hypoxic cell sensitizers and PLDR inhibitors].
    Ono K, Sasai K, Shibamoto Y, Tsutsui K, Fushiki M, Nishidai T, Takahashi M, Abe M.
    Gan No Rinsho; 1987 Oct; 33(13):1673-8. PubMed ID: 2961900
    [Abstract] [Full Text] [Related]

  • 14. [Development of new hypoxic cell radiosensitizer in Japan].
    Mori T, Murayama C.
    Gan No Rinsho; 1988 Oct; 34(13):1869-74. PubMed ID: 2974089
    [Abstract] [Full Text] [Related]

  • 15. [Experimental studies on radiosensitization of hypoxic cancer cells].
    Omura M.
    Nihon Sanka Fujinka Gakkai Zasshi; 1983 Nov; 35(11):1972-80. PubMed ID: 6663130
    [Abstract] [Full Text] [Related]

  • 16. A phase I/II study of the hypoxic cell sensitizer misonidazole as an adjunct to high fractional dose radiotherapy in patients with unresectable squamous cell carcinoma of the head and neck: a RTOG randomized study (#79-04).
    Lee DJ, Pajak TF, Stetz J, Order SE, Weissberg JB, Fischer JJ.
    Int J Radiat Oncol Biol Phys; 1989 Feb; 16(2):465-70. PubMed ID: 2646255
    [Abstract] [Full Text] [Related]

  • 17. Simultaneous paclitaxel and radiotherapy: initial clinical experience in lung cancer and other malignancies.
    Vogt HG, Martin T, Kolotas C, Schneider L, Strassmann G, Zamboglou N.
    Semin Oncol; 1997 Aug; 24(4 Suppl 12):S12-101-S12-105. PubMed ID: 9331131
    [Abstract] [Full Text] [Related]

  • 18. Clinical experience with misonidazole: high dose fractions versus daily low doses.
    Kogelnik HD.
    Cancer Clin Trials; 1980 Aug; 3(2):179-86. PubMed ID: 6253098
    [Abstract] [Full Text] [Related]

  • 19. Treatment of bladder carcinoma with irradiation combined with misonidazole.
    Papavasiliou C, Yiogarakis D, Davillas N, Seretakis L, Pappas J, Licourinas M, Theodorou C, Stathopoulos P, Katsoyianni C, Thanos A.
    Int J Radiat Oncol Biol Phys; 1983 Nov; 9(11):1631-3. PubMed ID: 6358156
    [Abstract] [Full Text] [Related]

  • 20. The Cambridge glioma trial of misonidazole and radiation therapy with associated pharmacokinetic studies.
    Bleehen NM.
    Cancer Clin Trials; 1980 Nov; 3(3):267-73. PubMed ID: 7002338
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.